{"id":"W4417065537","doi":"10.1016/s0140-6736(25)01778-7","title":"Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"Incyte","keywords":"Rituximab; Follicular lymphoma; Refractory (planetary science); Randomized controlled trial; Follicular phase; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021055,0.001829773,0.003310427,0.0004160253,0.0003162065,0.001211748,0.00103376,0.001751034,0.005367266],"category_scores_gemma":[0.001616017,0.0006022293,0.003083963,0.0005012211,0.001217932,0.001049281,0.0006323408,0.002731889,0.0008456793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001123579,"about_ca_system_score_gemma":0.0008856778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001390416,"about_ca_topic_score_gemma":0.003541501,"domain_scores_codex":[0.9992905,0.0003772342,0.0000419658,0.0001180632,0.00004768773,0.0001246355],"domain_scores_gemma":[0.9992892,0.000243316,0.0001656526,0.00005060519,0.00004890354,0.0002022384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9732109,0.001097463,0.0007356897,0.00187008,0.003690047,0.00004991476,0.0000492265,0.0001968221,0.001438821,0.000129865,0.001188331,0.01634287],"study_design_scores_gemma":[0.9827292,0.01259154,0.001493993,0.00009812746,0.001773231,0.00004637579,0.00003398858,0.00009982038,0.0001250333,0.0001350375,0.0008619736,0.00001175589],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9304346,0.05510415,0.0009735965,0.002422374,0.001255984,0.002976324,0.002114191,0.0001984401,0.004520284],"genre_scores_gemma":[0.9696194,0.01452519,0.002183331,0.003198632,0.0006626429,0.003586738,0.001910681,0.0000372728,0.004276054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005367266,"threshold_uncertainty_score":0.01795536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02299417291196583,"score_gpt":0.3258974189189807,"score_spread":0.3029032460070149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}